The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Inflammation in prostate carcinogenesis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Urisman, A., Molinaro, R. J., Fischer, N., Plummer, S. J., Casey, G., Klein, E. A., Malathi, K., Magi-Galluzzi, C., Tubbs, R. R., Ganem, D., et al. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020025 · Cited by 577
RetractedCoussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Thomas, A. C., & Campbell, J. H. (2000) · Cited by 2,800
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
Distinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
Ohashi, K., Burkart, V., Flohé, S., & Kolb, H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.558 · Cited by 1,606
Cytokines in cancer pathogenesis and cancer therapy
Dranoff, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1252 · Cited by 1,573
Th17: An Effector CD4 T Cell Lineage with Regulatory T Cell Ties
Weaver, C. T., Harrington, L. E., Mangan, P. R., Gavrieli, M., & Murphy, K. M. (2006) · Immunity · doi:10.1016/j.immuni.2006.06.002 · Cited by 1,422
Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins
Takeuchi, O., Sato, S., Horiuchi, T., Hoshino, K., Takeda, K., Dong, Z., Modlin, R. L., & Akira, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.10 · Cited by 1,329
The causes and prevention of cancer.
Ames, B. N., Gold, L. S., & Willett, W. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5258 · Cited by 1,319
MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)00139-2 · Cited by 1,306
Discrimination of bacterial lipoproteins by Toll-like receptor 6
Takeuchi, O., Kawai, T., Mühlradt, P. F., Morr, M., Radolf, J. D., Zychlinsky, A., Takeda, K., & Akira, S. (2001) · International Immunology · doi:10.1093/intimm/13.7.933 · Cited by 1,232
McNeal, J. E., Redwine, E. A., Freiha, F. S., & Stamey, T. A. (1988) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198812000-00001 · Cited by 1,182
Malaviya, R., Ikeda, T., Ross, E., & Abraham, S. N. (1996) · Nature · doi:10.1038/381077a0 · Cited by 1,123
IL-23 promotes tumour incidence and growth
Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., & Oft, M. (2006) · Nature · doi:10.1038/nature04808 · Cited by 1,018
Nelson, W. G., De Marzo, A. M., & Isaacs, W. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021562 · Cited by 918
Self-citationProliferative Inflammatory Atrophy of the Prostate
De Marzo, A. M., Marchi, V. L., Epstein, J. I., & Nelson, W. G. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65517-4 · Cited by 872
Self-citationInternational trends and patterns of prostate cancer incidence and mortality
Hsing, A. W., Tsao, L., & Devesa, S. S. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000101)85:1<60::aid-ijc11>3.0.co;2-b · Cited by 846
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-272_3 · Cited by 801
A common variant associated with prostate cancer in European and African populations
Amundadottir, L. T., Sulem, P., Gudmundsson, J., Helgason, A., Baker, A., Agnarsson, B. A., Sigurdsson, A., Benediktsdottir, K. R., Cazier, J.-B., Sainz, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1808 · Cited by 787
A Prospective Study of Dietary Fat and Risk of Prostate Cancer
Giovannucci, E., Rimm, E. B., Colditz, G. A., Stampfer, M. J., Ascherio, A., Chute, C. C., & Willett, W. C. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.19.1571 · Cited by 773
Cancer epidemiology in the last century and the next decade
Peto, J. (2001) · Nature · doi:10.1038/35077256 · Cited by 681
Normal Histology of the Prostate
McNeal, J. E. (1988) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198808000-00003 · Cited by 674
Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish
Sugimura, T., Wakabayashi, K., Nakagama, H., & Nagao, M. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03205.x · Cited by 674
Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men
Freedman, M. L., Haiman, C. A., Patterson, N., McDonald, G. J., Tandon, A., Waliszewska, A., Penney, K., Steen, R. G., Ardlie, K., John, E. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605832103 · Cited by 612
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1
Carpten, J., Nupponen, N., Isaacs, S., Sood, R., Robbins, C., Xu, J., Faruque, M., Moses, T., Ewing, C., Gillanders, E., et al. (2002) · Nature Genetics · doi:10.1038/ng823 · Cited by 525
Self-citationHajjar, A. M., O’Mahony, D. S., Ozinsky, A., Underhill, D. M., Aderem, A., Klebanoff, S. J., & Wilson, C. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.15 · Cited by 465
CD4+CD25high T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients
Miller, A. M., Lundberg, K., Özenci, V., Banham, A. H., Hellström, M., Egevad, L., & Pisa, P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7398 · Cited by 421
Epidemiologic association between prostatitis and prostate cancer
Dennis, L. K., Lynch, C. F., & Torner, J. C. (2002) · Urology · doi:10.1016/s0090-4295(02)01637-0 · Cited by 403
Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells
Chuang, T.-H., & Ulevitch, R. J. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00289-x · Cited by 397
Xu, J., Zheng, S. L., Komiya, A., Mychaleckyj, J. C., Isaacs, S. D., Hu, J. J., Sterling, D., Lange, E. M., Hawkins, G. A., Turner, A., et al. (2002) · Nature Genetics · doi:10.1038/ng994 · Cited by 392
Self-citationCentrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas.
Pihan, G. A., Wallace, J., Zhou, Y., & Doxsey, S. (2003) · PubMed · Cited by 374
The complex genetic epidemiology of prostate cancer
Schaid, D. J. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh072 · Cited by 368
TIR domain-containing adaptors define the specificity of TLR signaling
Yamamoto, M., Takeda, K., & Akira, S. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2003.10.006 · Cited by 343
Influence of cytokine gene polymorphisms on the development of prostate cancer.
McCarron, S. L., Edwards, S. M., Evans, P. R., Gibbs, R., Dearnaley, D. P., Dowe, A., Southgate, C., Easton, D. F., Eeles, R. A., & Howell, W. M. (2002) · PubMed · Cited by 336
SAMANTA, M., HARKINS, L., KLEMM, K., BRITT, W. J., & COBBS, C. S. (2003) · Journal of Urology · doi:10.1097/01.ju.0000080263.46164.97 · Cited by 316
Viruses, Immunity, and Cancer: Lessons from Hepatitis B
Chisari, F. V. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64980-2 · Cited by 304
CD4+ CD25+ Regulatory T Lymphocytes Inhibit Microbially Induced Colon Cancer in Rag2-Deficient Mice
Erdman, S. E., Poutahidis, T., Tomczak, M., Rogers, A. B., Cormier, K., Plank, B., Horwitz, B. H., & Fox, J. G. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63863-1 · Cited by 303
Prins, G. S., Birch, L. A., Couse, J. F., Choi, I., Katzenellenbogen, B. S., & Korach, K. S. (2001) · PubMed · Cited by 291
LOW P27 EXPRESSION PREDICTS POOR DISEASE-FREE SURVIVAL IN PATIENTS WITH PROSTATE CANCER
YANG, R. M., NAITOH, J., MURPHY, M., WANG, H.-J., PHILLIPSON, J., DEKERNION, J. B., LODA, M., & REITER, R. E. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)63776-5 · Cited by 278
Meta-Analysis of Measures of Sexual Activity and Prostate Cancer
Dennis, L. K., & Dawson, D. V. (2002) · Epidemiology · doi:10.1097/00001648-200201000-00012 · Cited by 274
Hassel, B. A., Zhou, A., Sotomayor, C., Maran, A., & Silverman, R. H. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05999.x · Cited by 270
Zha, S., Gage, W. R., Sauvageot, J., Saria, E. A., Putzi, M. J., Ewing, C. M., Faith, D., Nelson, W. G., Marzo, A. M. D., & Isaacs, W. B. (2001) · PubMed · Cited by 269
Self-citationOn The Frequency of Occurrence of Occult Carcinoma of the Prostate
Rich, A. R. (1935) · Journal of Urology · doi:10.1016/s0022-5347(17)72260-4 · Cited by 253
COHEN, R. J., SHANNON, B. A., McNEAL, J. E., SHANNON, T., & GARRETT, K. L. (2005) · Journal of Urology · doi:10.1097/01.ju.0000158161.15277.78 · Cited by 246
Epidemiology of Inflammation and Prostate Cancer
PLATZ, E. A., & De MARZO, A. M. (2004) · Journal of Urology · doi:10.1097/01.ju.0000108131.43160.77 · Cited by 243
Self-citationSteiner, G. E., Newman, M. E., Paikl, D., Stix, U., Memaran‐Dagda, N., Lee, C., & Marberger, M. J. (2003) · The Prostate · doi:10.1002/pros.10238 · Cited by 238
Prostate Stem Cell Compartments
De Marzo, A. M., Meeker, A. K., Epstein, J. I., & Coffey, D. S. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65632-5 · Cited by 230
Self-citationSimilarities of prostate and breast cancer: Evolution, diet, and estrogens
Coffey, D. S. (2001) · Urology · doi:10.1016/s0090-4295(00)00938-9 · Cited by 227
Sequence Variants ofToll-Like Receptor 4Are Associated with Prostate Cancer Risk
Zheng, S. L., Augustsson-Bälter, K., Chang, B., Hedelin, M., Li, L., Adami, H.-O., Bensen, J., Li, G., Johnasson, J.-E., Turner, A. R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3280 · Cited by 219
Self-citationA prospective study on intake of animal products and risk of prostate cancer
Michaud, D. S., Augustsson, K., Rimm, E. B., Stampfer, M. J., Willett, W. C., & Giovannucci, E. (2001) · Cancer Causes & Control · doi:10.1023/a:1011256201044 · Cited by 217
Intermediate Cells in Human Prostate Epithelium Are Enriched in Proliferative Inflammatory Atrophy
van Leenders, G. J. L. H., Gage, W. R., Hicks, J. L., van Balken, B., Aalders, T. W., Schalken, J. A., & De Marzo, A. M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64286-1 · Cited by 212
Self-citationCip/Kip proteins: more than just CDKs inhibitors: Figure 1.
Denicourt, C., & Dowdy, S. F. (2004) · Genes & Development · doi:10.1101/gad.1205304 · Cited by 203
Guo, Y., Sklar, G. N., Borkowski, A., & Kyprianou, N. (1997) · PubMed · Cited by 200
Atrophy and hyperplasia in the prostate proper
Franks, L. M. (1954) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700680234 · Cited by 200
Role of estrogens in development of prostate cancer
Härkönen, P. L., & Mäkelä, S. I. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.10.016 · Cited by 191
De Marzo, A. M., DeWeese, T. L., Platz, E. A., Meeker, A. K., Nakayama, M., Epstein, J. I., Isaacs, W. B., & Nelson, W. G. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10747 · Cited by 191
Self-citationSteiner, G. E., Stix, U., Handisurya, A., Willheim, M., Haitel, A., Reithmayr, F., Paikl, D., Ecker, R. C., Hrachowitz, K., Kramer, G., et al. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000081388.40145.65 · Cited by 185
Jacobs, E. J., Rodriguez, C., Mondul, A. M., Connell, C. J., Henley, S. J., Calle, E. E., & Thun, M. J. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji173 · Cited by 185
Hoda, S. A., & Hoda, R. S. (2008) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e318166130a · Cited by 183
Heterocyclic Amine Content of Cooked Meat and Risk of Prostate Cancer
Norrish, A. E., Ferguson, L. R., Knize, M. G., Felton, J. S., Sharpe, S. J., & Jackson, R. T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.23.2038 · Cited by 178
Implications for RNase L in Prostate Cancer Biology
Silverman, R. H. (2003) · Biochemistry · doi:10.1021/bi027147i · Cited by 177
Formation and Human Risk of Carcinogenic Heterocyclic Amines Formed from Natural Precursors in Meat
Knize, M. G., & Felton, J. S. (2005) · Nutrition Reviews · doi:10.1111/j.1753-4887.2005.tb00133.x · Cited by 176
Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis
Mahmud, S., Franco, E., & Aprikian, A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601416 · Cited by 171
Sequence Variants of Toll-Like Receptor 4 and Susceptibility to Prostate Cancer
Chen, Y.-C., Giovannucci, E., Lazarus, R., Kraft, P., Ketkar, S., & Hunter, D. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2078 · Cited by 167
Loss-of-Function of Nkx3.1 Promotes Increased Oxidative Damage in Prostate Carcinogenesis
Ouyang, X., DeWeese, T. L., Nelson, W. G., & Abate-Shen, C. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1948 · Cited by 163
Self-citationProstate cancer and sexually transmitted diseases: a meta-analysis.
Taylor, M. L., Mainous, A. G., & Wells, B. J. (2005) · PubMed · Cited by 163
Sequence Variants in Toll-Like Receptor Gene Cluster (TLR6-TLR1-TLR10) and Prostate Cancer Risk
Sun, J., Wiklund, F., Zheng, S. L., Chang, B., Balter, K., Li, L., Johansson, J.-E., Li, G., Adami, H.-O., Liu, W., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji070 · Cited by 161
Self-citationEjaculation Frequency and Subsequent Risk of Prostate Cancer
Leitzmann, M. F., Platz, E. A., Stampfer, M. J., Willett, W. C., & Giovannucci, E. (2004) · JAMA · doi:10.1001/jama.291.13.1578 · Cited by 155
Self-citationZambrano, A., Kalantari, M., Simoneau, A. R., Jensen, J. L., & Villarreal, L. P. (2002) · The Prostate · doi:10.1002/pros.10157 · Cited by 152
Mouse models of prostate carcinogenesis
Abate-Shen, C. T., & Shen, M. M. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02683-5 · Cited by 145
Peiser, L., de Winther, M. P. J., Makepeace, K., Hollinshead, M. S., Coull, P. A., Plested, J. S., Kodama, T., Moxon, E. R., & Gordon, S. (2002) · Infection and Immunity · doi:10.1128/iai.70.10.5346-5354.2002 · Cited by 141
Genetic Polymorphisms of Interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and Risk of Prostate Cancer
Michaud, D. S., Daugherty, S. E., Berndt, S. I., Platz, E. A., Yeager, M., Crawford, E. D., Hsing, A. W., Huang, W., & Hayes, R. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3987 · Cited by 133
Self-citationDesign of the Prostate Cancer Prevention Trial (PCPT)
Feigl, P., Blumenstein, B. A., Thompson, I. M., Crowley, J. J., Wolf, M., Kramer, B. S., Coltman, C. A., Brawley, O. W., & Ford, L. G. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)00xxx-m · Cited by 132
Molecular Pathways to Prostate Cancer
Gonzalgo, M. L., & Isaacs, W. B. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000085381.20139.b6 · Cited by 132
Self-citationGough, P. J., Greaves, D. R., & Gordon, S. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33292-2 · Cited by 123
H6D Polymorphism in Macrophage-Inhibitory Cytokine-1 Gene Associated With Prostate Cancer
Lindmark, F., Zheng, S. L., Wiklund, F. E., Bensen, J. T., Bälter, K. A., Chang, B., Hedelin, M., Clark, J., Stattin, P., Meyers, D. A., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh227 · Cited by 120
Self-citationRole of metabolism and viruses in aflatoxin-induced liver cancer
Groopman, J. D., & Kensler, T. W. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.09.020 · Cited by 113
Malathi, K., Paranjape, J. M., Bulanova, E., Shim, M., Guenther-Johnson, J. M., Faber, P. W., Eling, T. E., Williams, B. R. G., & Silverman, R. H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507551102 · Cited by 108
Low p27 expression predicts poor disease-free survival in patients with prostate cancer.
Yang, R. M., Naitoh, J., Murphy, M., et al. (1998) · PubMed · Cited by 107
Nakai, Y., Nelson, W. G., & Marzo, A. M. D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1336 · Cited by 106
Self-citationRoles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis
Shen, M. M., & Abate-Shen, C. T. (2003) · Developmental Dynamics · doi:10.1002/dvdy.10397 · Cited by 104
Xu, J., Zheng, S. L., Komiya, A., Mychaleckyj, J. C., Isaacs, S. D., Chang, B., Turner, A. R., Ewing, C. M., Wiley, K. E., Hawkins, G. A., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/345802 · Cited by 101
Self-citationGenetic Analysis of the RNASEL Gene in Hereditary, Familial, and Sporadic Prostate Cancer
Wiklund, F. E., Jonsson, B., Brookes, A. J., Strömqvist, L., Adolfsson, J., Emanuelsson, M., Adami, H., Bälter, K. A., & Grönberg, H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0982 · Cited by 93
Self-citationProstatic structure and function in relation to the etiology of prostatic cancer
Isaacs, J. T. (1983) · The Prostate · doi:10.1002/pros.2990040405 · Cited by 92
Huang, L., Pu, Y., Alam, S., et al. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.11.020 · Cited by 90
Sexual Behavior and Evidence for an Infectious Cause of Prostate Cancer
Strickler, H. D., & Goedert, J. J. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000781 · Cited by 88
Rennert, H., Zeigler-Johnson, C. M., Addya, K., Finley, M. J., Walker, A. H., Spangler, E., Leonard, D. G. B., Wein, A. J., Malkowicz, S. B., & Rebbeck, T. R. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0637 · Cited by 87
Molecular biology of prostate-cancer pathogenesis
Shand, R. L., & Gelmann, E. P. (2006) · Current Opinion in Urology · doi:10.1097/01.mou.0000193384.39351.64 · Cited by 85
Araki, Y., Andoh, A., Fujiyama, Y., & Bamba, T. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01094.x · Cited by 85
Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology
Meeker, A. K. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.11.002 · Cited by 81
Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene
Maier, C., Haeusler, J., Herkommer, K., Vesovic, Z., Hoegel, J. J., Vogel, W., & Paiss, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602401 · Cited by 79
Estrogenic Regulation of Signaling Pathways and Homeobox Genes During Rat Prostate Development
Huang, L., Pu, Y., Alam, S., Birch, L. A., & Prins, G. S. (2004) · Journal of Andrology · doi:10.1002/j.1939-4640.2004.tb02796.x · Cited by 78
Kasper, S. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20339 · Cited by 75
Ki-67 expression in early prostate cancer and associated pathological lesions.
Feneley, M. R., Young, M., Chinyama, C. N., Kirby, R. S., & Parkinson, M. C. (1996) · Journal of Clinical Pathology · doi:10.1136/jcp.49.9.741 · Cited by 72
Miller, D. C., Zheng, S. L., Dunn, R. L., Sarma, A. V., Montie, J. E., Lange, E. M., Meyers, D. A., Xu, J., & Cooney, K. A. (2003) · PubMed · Cited by 68
Self-citationRiley, D. E., Berger, R. E., Miner, D., & Krieger, J. N. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.6.1646-1652.1998 · Cited by 67
Prostate Cancer : Biology, Genetics, and the New Therapeutics
Chung, L. W. K., Isaacs, W. B., & Simons, J. W. (2007) · doi:10.1007/978-1-59745-224-3 · Cited by 64
Self-citationGerm-line alterations in MSR1 gene and prostate cancer risk.
Seppälä, E. H., Ikonen, T., Autio, V., Rökman, A., Mononen, N., Matikainen, M. P., Tammela, T. L. J., & Schleutker, J. (2003) · PubMed · Cited by 64
Cotena, A., Gordon, S., & Platt, N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6427 · Cited by 60
Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk
Lindmark, F., Zheng, S. L., Wiklund, F., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602729 · Cited by 56
Zheng, S. L., Liu, W., Wiklund, F. E., Dimitrov, L. M., Bälter, K. A., Sun, J., Adami, H., Johansson, J., Sun, J., Chang, B., et al. (2006) · The Prostate · doi:10.1002/pros.20496 · Cited by 52
Self-citationOzeki, Y., Tsutsui, H., Kawada, N., Suzuki, H., Kataoka, M., Kodama, T., Yano, I., Kaneda, K., & Kobayashi, K. (2006) · Microbial Pathogenesis · doi:10.1016/j.micpath.2005.12.006 · Cited by 49
Tsujimoto, Y., Takayama, H., Nonomura, N., Okuyama, Ä., & Aozasa, K. (2002) · The Prostate · doi:10.1002/pros.10116 · Cited by 42
An update on chemoprevention strategies in prostate cancer for 2006
Neill, M. G., & Fleshner, N. E. (2006) · Current Opinion in Urology · doi:10.1097/01.mou.0000193388.31727.d2 · Cited by 29
Tsujimoto, Y., Takakuwa, T., Takayama, H., Nishimura, K., Okuyama, Ä., Aozasa, K., & Nonomura, N. (2003) · The Prostate · doi:10.1002/pros.10333 · Cited by 28
Macrophage Scavenger Receptor 1 999C>T (R293X) Mutation and Risk of Prostate Cancer
Hope, Q., Bullock, S. L., Evans, C., Meitz-Hopkins, J. C., Hamel, N., Edwards, S. M., Severi, G., Dearnaley, D. P., Jhavar, S. G., Southgate, C., et al. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0202 · Cited by 21
The Epidemiology of Prostate Cancer—with a Focus on Nonsteroidal Anti-inflammatory Drugs
Chan, J. M., Feraco, A. M., Shuman, M., & Hernández–Dı́az, S. (2006) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2006.03.002 · Cited by 11
Cited by
Epidemiology of Prostate Cancer
Rawla, P. (2019) · World Journal of Oncology · doi:10.14740/wjon1191 · Cited by 2,776
Endogenous DNA damage as a source of genomic instability in cancer
Tubbs, A., & Nussenzweig, A. (2017) · Cell · doi:10.1016/j.cell.2017.01.002 · Cited by 1,452
Molecular genetics of prostate cancer: new prospects for old challenges
Shen, M. M., & Abate-Shen, C. (2010) · Genes & Development · doi:10.1101/gad.1965810 · Cited by 946
Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches
Sekhoacha, M., Riet, K., Motloung, P., Gumenku, L., Adegoke, A., & Mashele, S. (2022) · Molecules · doi:10.3390/molecules27175730 · Cited by 904
The Epidemiology of Prostate Cancer
Pernar, C. H., Ebot, E. M., Wilson, K. M., & Mucci, L. A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030361 · Cited by 773
Metadata
- Authors
- De Marzo, A. M., Platz, E. A., Sutcliffe, S., Xu, J., Grönberg, H., Drake, C. G., Nakai, Y., Isaacs, W. B., & Nelson, W. G.
- Venue
- Nature Reviews Cancer
- Published
- 2007-04
- Volume
- 7
- Issue
- 4
- Pages
- 256-269
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2059724367
- Cited by
- 1,621
- References
- 114
- FWCI
- 16.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.